IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

LOMBARDI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.523
AS - Asia 6.359
NA - Nord America 6.053
SA - Sud America 851
AF - Africa 181
OC - Oceania 80
Continente sconosciuto - Info sul continente non disponibili 1
Totale 20.048
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.639
IT - Italia 2.019
CN - Cina 1.883
SG - Singapore 1.862
DE - Germania 1.349
VN - Vietnam 660
GB - Regno Unito 634
HK - Hong Kong 623
BR - Brasile 599
SE - Svezia 565
RU - Federazione Russa 472
IN - India 338
FR - Francia 292
NL - Olanda 287
CA - Canada 242
FI - Finlandia 197
ID - Indonesia 179
IE - Irlanda 167
BD - Bangladesh 134
TR - Turchia 131
MX - Messico 121
ES - Italia 110
JP - Giappone 108
KR - Corea 105
AR - Argentina 79
AU - Australia 75
CI - Costa d'Avorio 68
AT - Austria 63
PL - Polonia 55
CO - Colombia 51
IQ - Iraq 40
EC - Ecuador 37
PK - Pakistan 37
BE - Belgio 35
CH - Svizzera 34
RO - Romania 34
PH - Filippine 31
TW - Taiwan 31
CL - Cile 30
ZA - Sudafrica 30
GR - Grecia 26
DK - Danimarca 25
IR - Iran 24
TH - Thailandia 23
VE - Venezuela 23
UA - Ucraina 22
CZ - Repubblica Ceca 21
SA - Arabia Saudita 20
PE - Perù 19
EG - Egitto 18
PT - Portogallo 18
MA - Marocco 15
HU - Ungheria 14
JO - Giordania 13
UZ - Uzbekistan 13
RS - Serbia 12
AE - Emirati Arabi Uniti 10
LT - Lituania 10
MY - Malesia 10
NP - Nepal 10
NO - Norvegia 9
DZ - Algeria 8
IL - Israele 8
KE - Kenya 8
SC - Seychelles 8
DO - Repubblica Dominicana 7
HR - Croazia 7
KZ - Kazakistan 7
OM - Oman 7
PA - Panama 7
PY - Paraguay 7
AL - Albania 6
AZ - Azerbaigian 6
BG - Bulgaria 6
GT - Guatemala 6
KG - Kirghizistan 6
NG - Nigeria 6
TN - Tunisia 6
BY - Bielorussia 5
ET - Etiopia 5
KH - Cambogia 5
LU - Lussemburgo 5
PS - Palestinian Territory 5
SK - Slovacchia (Repubblica Slovacca) 5
BB - Barbados 4
BO - Bolivia 4
CU - Cuba 4
HN - Honduras 4
LB - Libano 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
SV - El Salvador 4
TJ - Tagikistan 4
AM - Armenia 3
CR - Costa Rica 3
CY - Cipro 3
EE - Estonia 3
GE - Georgia 3
LV - Lettonia 3
SI - Slovenia 3
Totale 20.004
Salva come PNG Salva come JPEG
Città #
Singapore 1.032
Ashburn 901
Hanover 761
Milan 537
Hong Kong 526
Chandler 491
San Jose 410
Southend 369
Dallas 321
Frankfurt am Main 262
Beijing 255
Council Bluffs 230
Los Angeles 221
Hefei 195
New York 189
Ho Chi Minh City 159
Dublin 158
Hanoi 156
Toronto 141
Princeton 136
Helsinki 134
Santa Clara 133
Jakarta 130
Rome 127
Fairfield 106
Lauterbourg 102
Bengaluru 98
Guangzhou 91
Moscow 90
São Paulo 88
Boardman 87
Istanbul 83
Shanghai 81
Buffalo 73
Abidjan 68
Dong Ket 68
Munich 67
Seoul 64
The Dalles 62
Chicago 59
Houston 59
Tokyo 59
Columbus 55
Turin 55
Nuremberg 54
Cambridge 53
Wilmington 53
Phoenix 52
Ann Arbor 51
Cangzhou 51
Atlanta 44
Berlin 41
London 40
Pavia 40
Seattle 40
Da Nang 38
Lappeenranta 36
Des Moines 35
Genoa 34
Montreal 34
Warsaw 34
Naples 31
Rio de Janeiro 31
Tianjin 31
Amsterdam 30
Boston 30
Woodbridge 30
Haiphong 29
Nanjing 29
Brussels 28
Bologna 27
Washington 27
Chennai 26
Florence 26
Madrid 26
Redwood City 26
Denver 25
Mexico City 25
Brooklyn 24
Orem 23
Pontedera 23
Vienna 23
Wuhan 23
San Diego 22
Turku 22
Sydney 20
Verona 20
Quanzhou 19
Bogotá 18
Central 18
Chengdu 18
Kent 18
Manchester 18
Changsha 17
Dearborn 17
Piscataway 17
Poplar 17
Buenos Aires 16
Johannesburg 16
Lima 16
Totale 11.121
Salva come PNG Salva come JPEG
Nome #
Hepatitis C: Is eradication possible? 1.176
Deficient natural killer cell NKp30-mediated function and altered NCR3 splice variants in hepatocellular carcinoma 686
Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients 568
A clinical case of sepsis due to staphylococcus pettenkoferi 561
Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response 403
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 353
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: an observational cohort study 348
Response of an Italian reference institute to research challenges regarding a new pandemic: COVID-19 network 298
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 294
Anti-spike antibodies and neutralising antibody activity in people living with HIV vaccinated with COVID-19 mRNA-1273 vaccine: a prospective single-centre cohort study 292
Duration of quarantine in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a question needing an answer 256
Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes 255
The impact of HIV infection and men who have sex with men status on hepatitis A infection: The experience of two tertiary centres in Northern Italy during the 2017 outbreak and in the 2009-2016 period 237
COVID-19: What happened to the healthcare workers of a research and teaching hospital in Milan, Italy? 236
Mucormycosis in CAPA, a possible fungal super-infection 225
Production of anti-{PF}4 antibodies in antiphospholipid antibody-positive patients is not affected by {COVID}-19 vaccination 218
Integrase inhibitors use and CMV infection predict immune recovery in peolple living with HIV starting first-line therapy 216
Characteristics of 1573 healthcare workers who underwent nasopharyngeal swab testing for SARS-CoV-2 in Milan, Lombardy, Italy 215
Multidrug‐resistant gram‐negative bacteria decolonization in immunocompromised patients : a focus on fecal microbiota transplantation 212
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy : comment 211
Antiviral Treatments for Influenza 210
Congenital Hepatic Fibrosis as a Cause of Recurrent Cholangitis: A Case Report and Review of the Literature 204
Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results 203
ITPA and SLC29A1 Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease Inhibitors 201
SARS-CoV-2 anti-spike antibody titres after vaccination with BNT162b2 in naïve and previously infected individuals 201
Detection of liver steatosis with a novel ultrasound-based technique : A pilot study using MRI-derived proton density fat fraction as the gold standard 197
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 196
A Response to: Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) 196
Anterior uveitis onset after bnt162b2 vaccination: is this just a coincidence? 196
Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis 195
Long-term dynamics of natural killer cells in response to SARS-CoV-2 vaccination: Persistently enhanced activity postvaccination 194
Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infection 193
Vaccination with COVID-19 mRNA-1273 is not associated with HIV-RNA blips among people with HIV on ART: a retrospective cohort study 191
Pulmonary embolism in a young pregnant woman with COVID-19 190
Immune checkpoint inhibitors in people living with HIV/AIDS : facts and controversies 190
Seroprevalence of anti-SARS-CoV-2 IgG among healthcare workers of a large university hospital in Milan, Lombardy, Italy: A cross-sectional study 188
New Antibiotics Against Multidrug-Resistant Gram-Negative Bacteria in Liver Transplantation: Clinical Perspectives, Toxicity, and PK/PD Properties 187
Clinical characteristics of healthcare workers with SARS-CoV-2 infection after vaccination with BNT162b2 vaccine 187
Nasopharyngeal Testing among Healthcare Workers (HCWs) of a Large University Hospital in Milan, Italy during Two Epidemic Waves of COVID-19 186
Perfusion fluid-related infections in liver transplant recipients: A 5-year, single-center, retrospective study 182
Renal safety in 3264 HCV patients treated with DAA-based regimens : results from a large Italian real-life study 182
Characteristics of 1,573 healthcare workers who underwent nasopharyngeal swab for SARS-CoV-2 in Milano, Lombardy, Italy 182
Increased risk of urticaria/angioedema after BNT162b2 mRNA COVID-19 vaccine in health care workers taking ACE inhibitors 177
Air pollution exposure, SARS-CoV-2 infection, and immune response in a cohort of healthcare workers of a large university hospital in Milan, Italy 176
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous daa failure 172
Incidence, microbiological and immunological characteristics of ventilator-associated pneumonia assessed by bronchoalveolar lavage and endotracheal aspirate in a prospective cohort of COVID-19 patients: CoV-AP study 171
Epidemiology, Clinical Manifestations, and Outcome of Mucormycosis in Solid Organ Transplant Recipients: A Systematic Review of Reported Cases 171
Inflammatory biomarkers in pregnant women with COVID-19: a retrospective cohort study 171
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients 169
Tracking the immune response profiles elicited by the BNT162b2 vaccine in COVID-19 unexperienced and experienced individuals 168
Dealing With Antibiotic Prophylaxis in Lung Transplantation in the Era of Multidrug Resistance: The Milano Algorithm 168
Innate and adaptive lymphocytes in non-tuberculous mycobacteria lung disease : A review 167
Transient increase in plasma HIV RNA after COVID-19 vaccination with mRNA-1272 167
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment With Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients 162
A new algorithm shows superior ability to discriminate liver fibrosis stages in chronic hepatitis C 162
COVID-19 Vaccine in Lung and Liver Transplant Recipients Exceeds Expectations: An Italian Real-Life Experience on Immunogenicity and Clinical Efficacy of BNT162b2 Vaccine 160
Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for {COVID}-19: comment 160
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape 158
Treatment of 320 genotype 3 cirrhotic patients with 12 weeks Sofosbuvir/Velpatasvir with or without ribavirin: real life experience from Italy 158
Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) 153
T-cell exhaustion in mycobacterium tuberculosis and nontuberculous mycobacteria infection : Pathophysiology and therapeutic perspectives 149
Prophylaxis of spontaneous bacterial peritonitis : Is there still room for quinolones? 148
Antiviral treatment selection for SARS-CoV-2 pneumonia 147
Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort Study 147
Predictors of starting antimicrobial treatment in patients with nontuberculous mycobacterial lung disease in the Italian scenario: a SITA GIOVANI-IRENE promoted web-survey 144
Increase in invasive group A streptococcal infections in Milan, Italy: a genomic and clinical characterization 143
Carbapenem or new β-lactam-β-lactamase inhibitors? An Italian survey supported by SITA, SIMIT and SIAARTI to identify the factors affecting empiric antimicrobial therapy choice in real-life clinical practice 142
Prospective Study on Incidence, Risk Factors and Outcome of Recurrent Clostridioides difficile Infections 142
Re: 'Which trial do we need? Culture of preservation fluid in abdominal-organ transplant recipients' by Manuel et al 140
Side effects among healthcare workers from a large Milan university hospital after second dose of BNT162b2 mRNA COVID-19 vaccine 140
Infectious events in patients treated with immune checkpoint inhibitors, chimeric antigen receptor T cells and Bi-specific T-cell engagers: a review of registration studies 135
Pneumocystis jirovecii pneumonia in HIV-negative patients, a frequently overlooked problem. A case series from a large Italian center 134
The possible role of gut microbiota and microbial translocation profiling during chemo-free treatment of lymphoid malignancies 134
The Interplay between Gut Microbiota and the Immune System in Liver Transplant Recipients and Its Role in Infections 134
RE : Effects of Long-Term Norfloxacin Therapy in Patients With Advanced Cirrhosis 129
Application of Syndromic Panels for respiratory Tract Infections in Lung Transplantation: A Critical Review on Current Evidence and Future Perspectives 127
The COVID-19 pandemic preparedness ... or lack thereof: from China to Italy 122
Treatable traits and challenges in the clinical management of non-tuberculous mycobacteria lung disease in people with cystic fibrosis 120
Comments on PD-1 Inhibitor for Disseminated Mycobacterium avium Infection in a Person Living With HIV 118
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome 118
Patients with chronic hepatitis C receiving treatment with direct acting antivirals: How is this population changing? 114
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres 112
Endogenous antibody response to SARS-CoV-2 in patients who received monoclonal antibodies against COVID-19: A systematic review 110
Mortality of Patients With Candidemia and COVID-19: A Systematic Review With Meta-analysis 109
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 108
The impact of rifaximin in the prevention of bacterial infections in cirrhosis 108
Hypothermic oxygenated machine-perfusion fluid-related infection in a liver transplant recipient: First case report in the literature 108
The use of intrahepatic portosystemic shunt in HIV positive patients : A retrospective multicentric study 106
Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis: A prospective single center study 105
An eight-year experience of Nocardia infection in Italy: does immunosuppression matter? 105
Non-tuberculous mycobacteria lung disease due to Mycobacterium chimaera in a 67-year-old man treated with immune checkpoint inhibitors for lung adenocarcinoma: infection due to dysregulated immunity? 105
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 104
How to tailor recommendations on the treatment of multi-drug resistant Gram-negative infections at country level integrating antibiotic stewardship principles within the GRADE-ADOLOPMENT framework 103
Review article : immune checkpoint inhibitors and the liver, from therapeutic efficacy to side effects 103
Non-tuberculous mycobacterial infections during cancer therapy with immune checkpoint inhibitors: a systematic review 98
Immunogenicity and effectiveness of BNT162b2 COVID-19 vaccine in a cohort of healthcare workers in Milan (Lombardy Region, Northern Italy) 98
Is a radiological score needed to define the severity of Nontuberculous mycobacteria lung disease? 97
Early Onset Mycoplasma spp. Infection After Kidney Transplantation: A Systematic Review 97
Adaptive Natural Killer Cell Functional Recovery in Hepatitis C Virus Cured Patients 97
Cutaneous septic emboli from Candida glabrata in a haematological patient 96
Totale 19.297
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.186
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.186
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021192 0 0 0 0 0 0 0 0 0 0 30 162
2021/20222.843 49 72 108 113 154 178 463 581 429 211 159 326
2022/20232.177 254 244 154 197 184 294 94 152 220 91 212 81
2023/20242.018 102 121 126 142 433 193 165 107 98 98 204 229
2024/20254.305 224 345 152 335 245 261 268 398 288 487 535 767
2025/20268.317 869 647 911 761 757 525 1.294 431 864 635 623 0
Totale 20.653